Literature DB >> 23525799

Colorectal surveillance in Lynch syndrome families.

Wouter H de Vos tot Nederveen Cappel1, Heikki J Järvinen, Patrick M Lynch, Christoph Engel, Jukka-Pekka Mecklin, Hans F A Vasen.   

Abstract

Lynch syndrome (LS) is an autosomal dominant disorder caused by a mutation in one of the mismatch repair genes. Mutation carriers have a life-time risk of developing colorectal cancer (CRC) of between 25 and 75 %. Since the importance of a centralized organization of surveillance was emphasized in the late 1980s, the number of registered LS families with a known mutation has increased enormously worldwide. Large-scale surveillance programs of these families have achieved a 62 % reduction in incidence of CRC and a 65-70 % decrease in mortality. Nevertheless, the risk of CRC is still substantial even when included in a program and the most optimal surveillance interval for gene carriers remains unknown. Hopefully, improvements in high quality colonoscopy and new endoscopic visualization techniques will further reduce CRC risk in those included in a surveillance program.

Entities:  

Mesh:

Year:  2013        PMID: 23525799     DOI: 10.1007/s10689-013-9631-1

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  23 in total

1.  Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation.

Authors:  S Stuckless; J S Green; M Morgenstern; C Kennedy; R C Green; M O Woods; W Fitzgerald; J Cox; P S Parfrey
Journal:  Clin Genet       Date:  2011-11-15       Impact factor: 4.438

Review 2.  Field effect in cancer-an update.

Authors:  Hong Chai; Robert E Brown
Journal:  Ann Clin Lab Sci       Date:  2009       Impact factor: 1.256

3.  Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands.

Authors:  H F Vasen; F C den Hartog Jager; F H Menko; F M Nagengast
Journal:  Am J Med       Date:  1989-03       Impact factor: 4.965

4.  Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families.

Authors:  Wouter H de Vos tot Nederveen Cappel; Fokko M Nagengast; Gerrit Griffioen; Fred H Menko; Babs G Taal; Jan H Kleibeuker; Hans F Vasen
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

5.  Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome)

Authors:  H F Vasen; F M Nagengast; P M Khan
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

6.  One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.

Authors:  Hans F A Vasen; Mohamed Abdirahman; Richard Brohet; Alexandra M J Langers; Jan H Kleibeuker; Mariette van Kouwen; Jan Jacob Koornstra; Henk Boot; Annemieke Cats; Evelien Dekker; Silvia Sanduleanu; Jan-Werner Poley; James C H Hardwick; Wouter H de Vos Tot Nederveen Cappel; Andrea E van der Meulen-de Jong; T Gie Tan; Maarten A J M Jacobs; Faig Lall A Mohamed; Sijbrand Y de Boer; Paul C van de Meeberg; Marie-Louise Verhulst; Jan M Salemans; Nico van Bentem; B Dik Westerveld; Juda Vecht; Fokko M Nagengast
Journal:  Gastroenterology       Date:  2010-03-02       Impact factor: 22.682

7.  Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).

Authors:  Elena M Stoffel; D Kim Turgeon; David H Stockwell; Lili Zhao; Daniel P Normolle; Missy K Tuck; Robert S Bresalier; Norman E Marcon; John A Baron; Mack T Ruffin; Dean E Brenner; Sapna Syngal
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

8.  The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research.

Authors:  Edwin J Lai; Audrey H Calderwood; Gheorghe Doros; Oren K Fix; Brian C Jacobson
Journal:  Gastrointest Endosc       Date:  2009-01-10       Impact factor: 9.427

9.  Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening.

Authors:  R Hüneburg; F Lammert; C Rabe; N Rahner; P Kahl; R Büttner; P Propping; T Sauerbruch; C Lamberti
Journal:  Endoscopy       Date:  2009-04-01       Impact factor: 10.093

10.  Screening for colorectal carcinoma in cancer family syndrome kindreds.

Authors:  J P Mecklin; H J Järvinen; S Aukee; I Elomaa; K Karjalainen
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

View more
  15 in total

1.  Worldwide Practice Patterns in Lynch Syndrome Diagnosis and Management, Based on Data From the International Mismatch Repair Consortium.

Authors:  Jennifer Y Pan; Robert W Haile; Allyson Templeton; Finlay Macrae; FeiFei Qin; Vandana Sundaram; Uri Ladabaum
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-24       Impact factor: 11.382

2.  When Should Patients Undergo Genetic Testing for Hereditary Colon Cancer Syndromes?

Authors:  Gregory Idos; Samir Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2017-11-10       Impact factor: 11.382

3.  CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.

Authors:  Aysel Ahadova; Magnus von Knebel Doeberitz; Hendrik Bläker; Matthias Kloor
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

Review 4.  Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.

Authors:  S G Patel; J T Lowery; D Gatof; D J Ahnen
Journal:  Dig Dis Sci       Date:  2015-02-20       Impact factor: 3.199

Review 5.  Clinical significance of microsatellite instability in colorectal cancer.

Authors:  Matthias Kloor; Laura Staffa; Aysel Ahadova; Magnus von Knebel Doeberitz
Journal:  Langenbecks Arch Surg       Date:  2013-09-19       Impact factor: 3.445

Review 6.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

7.  Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.

Authors:  Yanni Chen; Michelle Peate; Rajneesh Kaur; Bettina Meiser; Tim Wong; Judy Kirk; Robyn L Ward; Annabel Goodwin; Finlay Macrae; Janet Hiller; Alison H Trainer; Gillian Mitchell
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

8.  Quality of colonoscopy in Lynch syndrome.

Authors:  Yaron Niv; Gabriela Moeslein; Hans F A Vasen; Judith Karner-Hanusch; Jan Lubinsky; Christoph Gasche
Journal:  Endosc Int Open       Date:  2014-10-24

9.  Physical activity and the risk of colorectal cancer in Lynch syndrome.

Authors:  S Ghazaleh Dashti; Aung Ko Win; Sheetal S Hardikar; Stephen E Glombicki; Sheila Mallenahalli; Selvi Thirumurthi; Susan K Peterson; Y Nancy You; Daniel D Buchanan; Jane C Figueiredo; Peter T Campbell; Steven Gallinger; Polly A Newcomb; John D Potter; Noralane M Lindor; Loic Le Marchand; Robert W Haile; John L Hopper; Mark A Jenkins; Karen M Basen-Engquist; Patrick M Lynch; Mala Pande
Journal:  Int J Cancer       Date:  2018-08-07       Impact factor: 7.316

10.  Population Landscape of Familial Cancer.

Authors:  C Frank; M Fallah; J Sundquist; A Hemminki; K Hemminki
Journal:  Sci Rep       Date:  2015-08-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.